Our focus is to see that we are growing faster than the industry and, whichever product we launch, we do better than competition. We try and manage our operations better than competition. Essentially, we try to be better than what… — Dilip Shanghvi Copy Share Image
The Ranbaxy acquisition doesn't preclude us from making more large acquisitions. The important issue is whether we have the management bandwidth to handle the acquisition. — Dilip Shanghvi Copy Share Image
Generally, we have competed with ourselves... because I feel that if I compete against somebody, it causes stress. I don't want the process of… — Dilip Shanghvi Copy Share Image
Our focus is to see that we are growing faster than the industry and, whichever product we launch, we do better than competition. We… — Dilip Shanghvi Copy Share Image
Sun is seeking some products that we don't have or technologies that we don't have. — Dilip Shanghvi Copy Share Image
The Ranbaxy acquisition doesn't preclude us from making more large acquisitions. The important issue is whether we have the management bandwidth to handle the… — Dilip Shanghvi Copy Share Image
Sun Pharma's relationship with AML is on an arm's-length basis. As investors have expressed concerns regarding this arrangement, we are in the process of… — Dilip Shanghvi Copy Share Image
The reason we don't give a date by which we will acquire something is because we don't want to create pressure on ourselves to… — Dilip Shanghvi Copy Share Image
India is a large market where our focus will be to grow faster than the market and add few percentage points to our market… — Dilip Shanghvi Copy Share Image
We follow highest level of corporate governance, which is in line with a global company like ours. — Dilip Shanghvi Copy Share Image
